Cyrille Hulin Selected Research

carfilzomib

1/2022	Depth of response and response kinetics of isatuximab plus carfilzomib and dexamethasone in relapsed multiple myeloma.
1/2022	Carfilzomib maintenance in newly diagnosed non-transplant eligible multiple myeloma.
1/2019	Carfilzomib Weekly plus Melphalan and Prednisone in Newly Diagnosed Transplant-Ineligible Multiple Myeloma (IFM 2012-03): A Phase I Trial.
5/2015	Phase 1/2 study of carfilzomib plus melphalan and prednisone in patients aged over 65 years with newly diagnosed multiple myeloma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Cyrille Hulin Research Topics

Disease

88	Multiple Myeloma 01/2024 - 02/2002
11	Disease Progression 10/2021 - 10/2013
8	Peripheral Nervous System Diseases (PNS Diseases) 02/2021 - 08/2009
7	Neoplasms (Cancer) 01/2024 - 09/2014
6	Neutropenia 01/2023 - 08/2009
5	Residual Neoplasm 01/2022 - 12/2016
4	Lymphopenia (Lymphocytopenia) 11/2021 - 01/2019
4	Infections 01/2018 - 02/2006
3	Vomiting 01/2023 - 03/2012
2	Nausea 01/2023 - 03/2012
2	Thrombocytopenia (Thrombopenia) 01/2023 - 10/2018
2	Sepsis (Septicemia) 11/2022 - 05/2020
2	Frailty 01/2022 - 01/2020
2	Pneumonia (Pneumonitis) 11/2021 - 01/2019
2	Febrile Neutropenia 05/2020 - 01/2019
2	Constipation 05/2012 - 03/2012
1	Rheumatic Diseases (Rheumatism) 08/2023
1	Monoclonal Gammopathy of Undetermined Significance 08/2023
1	Alopecia (Baldness) 01/2023
1	Mucositis 01/2023
1	Hypertension (High Blood Pressure) 10/2021
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2021
1	Septic Shock (Toxic Shock Syndrome) 10/2021
1	Bone Diseases (Bone Disease) 12/2020
1	Hepatitis B 05/2020
1	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 05/2020
1	Anemia 01/2019
1	Diarrhea 10/2018
1	Leukemia 10/2017
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2017
1	Plasma Cell Leukemia 01/2016
1	Venous Thromboembolism 10/2013
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 12/2012
1	Second Primary Neoplasms (Neoplasms, Second) 05/2012
1	Fatigue 05/2012
1	Sleepiness 03/2012
1	Acute Kidney Injury (Acute Renal Failure) 10/2011
1	Chromosome Aberrations (Chromosome Abnormalities) 10/2010
1	Pathologic Complete Response 11/2006
1	Hemorrhage 02/2006
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2002

Drug/Important Bio-Agent (IBA)

39	Dexamethasone (Maxidex)FDA LinkGeneric 12/2023 - 02/2006
26	Bortezomib (Velcade)FDA Link 01/2024 - 11/2006
20	Lenalidomide (CC 5013)FDA Link 12/2023 - 05/2012
20	Thalidomide (Thalomid)FDA Link 01/2023 - 11/2006
17	Melphalan (Alkeran)FDA LinkGeneric 01/2024 - 02/2002
15	daratumumabIBA 12/2023 - 01/2019
11	Prednisone (Sone)FDA LinkGeneric 01/2019 - 01/2002
8	pomalidomideIBA 01/2023 - 03/2013
5	Proteasome InhibitorsIBA 10/2023 - 12/2012
4	carfilzomibIBA 01/2022 - 05/2015
4	isatuximabIBA 01/2022 - 10/2021
3	Monoclonal AntibodiesIBA 10/2023 - 01/2020
3	Immunomodulating AgentsIBA 11/2022 - 10/2013
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2018 - 01/2016
2	belantamab mafodotinIBA 10/2023 - 01/2020
2	Immunoconjugates (Immunoconjugate)IBA 10/2023 - 01/2020
2	Proteins (Proteins, Gene)FDA Link 04/2023 - 12/2016
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 12/2020 - 09/2017
2	Drug CombinationsIBA 11/2020 - 09/2014
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2018 - 07/2014
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2016 - 10/2010
1	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 10/2023
1	Antirheumatic Agents (DMARD)IBA 08/2023
1	Janus Kinase InhibitorsIBA 08/2023
1	plerixafor FDA Link 03/2023
1	iberdomideIBA 11/2022
1	ixazomibIBA 01/2022
1	antineoplaston A10 (A 10)IBA 01/2022
1	thiamine triphosphorate (TTP)IBA 02/2021
1	fluoromethylcholineIBA 09/2020
1	Choline (Choline Chloride)IBA 05/2020
1	B-Cell Maturation AntigenIBA 01/2020
1	vasectrin IIIIBA 01/2020
1	EnzymesIBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 12/2018
1	Hemoglobins (Hemoglobin)IBA 01/2018
1	Thrombin FDA Link 01/2017
1	Cytidine Monophosphate (CMP)IBA 05/2015
1	Bendamustine Hydrochloride FDA Link 02/2015
1	Vincristine (Oncovin)FDA LinkGeneric 10/2010
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2002
1	Methylprednisolone FDA LinkGeneric 01/2002

Therapy/Procedure

26	Therapeutics 12/2023 - 02/2006
25	Stem Cell Transplantation 01/2023 - 02/2002
9	Transplantation 12/2023 - 10/2010
5	Drug Therapy (Chemotherapy) 11/2021 - 12/2003
3	Salvage Therapy 01/2023 - 05/2012
3	Intravenous Administration 10/2022 - 12/2008
2	Subcutaneous Injections 12/2012 - 12/2008
1	Hematopoietic Stem Cell Transplantation 01/2024
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2023
1	Intravenous Infusions 01/2020
1	Retreatment 01/2019
1	Renal Dialysis (Hemodialysis) 10/2011
1	Autologous Transplantation 11/2008
1	Combination Drug Therapy (Combination Chemotherapy) 10/2007
1	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 02/2002